Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Weidemann

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Journal of the American College of Cardiology|December 3, 2014
Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?Eloisa Arbustini, Frank Weidemann, Jennifer L Hall
Circulation|November 10, 2004
Letter regarding article by Yu et al, "Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy"Frank Weidemann, Bart Bijnens, Jörg M Strotmann
Journal of the American College of Cardiology|April 4, 2015
Reply: The importance of cardiac cycle in the imaging criteria for left ventricular noncompactionEloisa Arbustini, Frank Weidemann, Jennifer L Hall
International Journal of Molecular Sciences|February 15, 2022
Chaperone Therapy in Fabry DiseaseFrank Weidemann, Ana Jovanovic, Ken Herrmann, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 2, 2010
The different faces of echocardiographic left ventricular hypertrophy: clues to the etiologyFrank Weidemann, Markus Niemann, Georg Ertl, et al.
Therapeutics and Clinical Risk Management|July 2, 2020
Diagnosis and Screening of Patients with Fabry DiseaseIrfan Vardarli, Christoph Rischpler, Ken Herrmann, et al.
Clinical Therapeutics|December 6, 2007
Progression of Fabry cardiomyopathyJörg Strotmann, Frank Breunig, Christoph Wanner, et al.
Current Pharmaceutical Design|December 9, 2014
The Fabry cardiomyopathy - diagnostic approach and current treatmentFrank Weidemann, Georg Ertl, Christoph Wanner, et al.
Echocardiography (Mount Kisco, N.Y.)|January 29, 2016
Thrombus-in-Transit Following Watchman Device ImplantationJulia Wallenborn, Frank Weidemann, Björn Lengenfelder, et al.
Molecular Genetics and Metabolism|December 31, 2018
Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA studyFrank Weidemann, Meinrad Beer, Martina Kralewski, et al.
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Journal of the American College of Cardiology|December 3, 2014
Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?Eloisa Arbustini, Frank Weidemann, Jennifer L Hall
Circulation|November 10, 2004
Letter regarding article by Yu et al, "Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy"Frank Weidemann, Bart Bijnens, Jörg M Strotmann
Journal of the American College of Cardiology|April 4, 2015
Reply: The importance of cardiac cycle in the imaging criteria for left ventricular noncompactionEloisa Arbustini, Frank Weidemann, Jennifer L Hall
International Journal of Molecular Sciences|February 15, 2022
Chaperone Therapy in Fabry DiseaseFrank Weidemann, Ana Jovanovic, Ken Herrmann, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 2, 2010
The different faces of echocardiographic left ventricular hypertrophy: clues to the etiologyFrank Weidemann, Markus Niemann, Georg Ertl, et al.
Therapeutics and Clinical Risk Management|July 2, 2020
Diagnosis and Screening of Patients with Fabry DiseaseIrfan Vardarli, Christoph Rischpler, Ken Herrmann, et al.
Clinical Therapeutics|December 6, 2007
Progression of Fabry cardiomyopathyJörg Strotmann, Frank Breunig, Christoph Wanner, et al.
Current Pharmaceutical Design|December 9, 2014
The Fabry cardiomyopathy - diagnostic approach and current treatmentFrank Weidemann, Georg Ertl, Christoph Wanner, et al.
Echocardiography (Mount Kisco, N.Y.)|January 29, 2016
Thrombus-in-Transit Following Watchman Device ImplantationJulia Wallenborn, Frank Weidemann, Björn Lengenfelder, et al.
Molecular Genetics and Metabolism|December 31, 2018
Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA studyFrank Weidemann, Meinrad Beer, Martina Kralewski, et al.
Pageof 16